Search Results  for '600572.SS'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Zhejiang CONBA Pharmaceutical Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 Mar 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - ZHEJIANG CONBA PHARMACEUTICAL CO., LTD. (600572-SH)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Mar 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Zhejiang Conba Pharmaceutical Co., Ltd.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

05 Mar 2015 Wright Reports 56 $75.00

Zhejiang CONBA Pharmaceutical Co., Ltd.: Upgraded to Above Average

30 Dec 2014 Sadif Analytics Prime 3 $10.00

Zhejiang Conba Pharmaceutical Co., Ltd. (600572) - Financial Analysis Review

Zhejiang Conba Pharmaceutical Co., Ltd. (600572) - Financial Analysis Review Summary Zhejiang CONBA Pharmaceutical Co.,...

11 Dec 2014 GlobalData 23 $125.00

华融证券_公司研究_医药行业_康恩贝(600572):收购医药电商,有利于长远发展_推荐_张科然_20141204

08 Dec 2014 Huarong Securities Co., Ltd 9 $25.00

Is Zhejiang CONBA Pharmaceutical Co., Ltd. Fairly Valued?

13 Nov 2014 Sadif Analytics Prime 12 $25.00

Is Zhejiang CONBA Pharmaceutical Co., Ltd. the Safe Haven Investors Seek?

25 Sep 2014 Sadif Analytics Prime 12 $25.00

Company Snapshot - Zhejiang Conba Pharmaceuticals

A director at Zhejiang Conba Pharmaceuticals bought 250,000 shares at 17.180CNY and the significance rating of the trade was ...

05 Sep 2014 Directors Deals Ltd. 1 $12.00

Zhejiang CONBA Pharmaceutical Co., Ltd.: Downgraded to Average

12 Aug 2014 Sadif Analytics Prime 3 $10.00